查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493228

間質幹細胞市場規模、佔有率、趨勢分析報告：按產品/服務、按工作流程類型、按類型、按分離源、按適應症、按應用、按地區、細分市場預測，2024-2030

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow Type, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

間質幹細胞市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，2024年至2030年，全球間質幹細胞（MSC）市場規模將以12.92%的複合年成長率擴張，預計2030年將達到72.7億美元。

基於間質幹細胞（MSC）的研究的快速成長及其對再生醫學領域的影響預計將推動該產業的擴張。此外，細胞療法的不斷發展也有望推動間質幹細胞市場的投資。大型工業公司透過收購業務策略瞄準較小的公司和新興企業，以提高其在市場上的影響力。

基於間質幹細胞的強大產品線，加上間質幹細胞的新興應用，預計將加速產業成長。例如，2022年，美國FDA已核准約19種幹細胞療法用於各種危及生命的疾病。其中包括 BMS 的 BREYANZI、諾華的 ALLOCORD 和 KYMIRAH。此外，許多公司正在探索間質幹細胞作為治療發炎疾病的治療方案的潛力，從而促進市場成長。

例如，2022 年 1 月，Century Therapeutics 和百時美施貴寶建立了合作夥伴關係，以擴大 IPSC 衍生的同種異體細胞療法。此外，Takeda/TiGenix 的 3 期臨床試驗納入了間質幹細胞治療克隆氏症的複雜肛門周圍瘻管。這是截至 2020 年 9 月最成功的後期臨床試驗。此外，2022年8月，AGC Biologics 將與人類間質幹細胞供應商 RoosterBio Inc. 合作，為危及生命的疾病提供經過臨床驗證的先進治療方法。這些因素預計將推動主要企業提供的幹細胞產品的利用並加劇市場競爭。

為了保持其市場地位，市場參與企業正致力於透過廣泛的研究和開發以及與其他主要企業建立聯盟和合作夥伴關係來擴大其產品範圍。由於最近爆發的COVID-19，多個研究機構和學術機構正在專注於開發利用間質幹細胞的治療方法。

間質幹細胞市場報告亮點

  • 產品領域在這一領域佔據主導地位，2023 年收益佔有率最大，為 78.89%。在產品中，細胞和細胞株係部門已成為該部門收益的重要貢獻者。
  • 根據工作流程類型，培養和冷凍保存領域在行業中佔據主導地位，2023 年收益佔有率為 44.55%。該領域的成長歸因於新興經濟體對低溫保存服務的高需求以及醫療基礎設施的加強。
  • 2023年同質MSC領域銷售比重高達56.60%。這是由於間質幹細胞在臨床應用上的高安全性。
  • 骨髓細分市場佔據主導地位，2023年佔最大銷售佔有率，為24.56%。骨髓是間質細胞分離的主要來源。
  • 疾病模型應用領域在此應用領域佔據主導地位，2023年收益佔有率最大，為35.23%。使用具有患者特異性MSC 的細胞介導的疾病模型為病理學研究提供了理想的工具。
  • 北美地區主導市場，2023 年收益佔有率最大，為 45.11%。該地區的高銷售佔有率得益於政府監管支持以及細胞療法在慢性病中日益廣泛的應用。

目錄

第1章間質幹細胞市場：調查方法與範圍

第2章間間質幹細胞市場：執行摘要

  • 市場概述
  • 段簡介
  • 競爭格局概覽

第3章間質幹細胞市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 產業分析工具

第4章 產品和服務的業務分析

  • 產品和服務細分儀表板
  • 間間質幹細胞市場產品與服務波動分析
  • 間質幹細胞市場規模和趨勢分析（按產品和服務），2018-2030
  • 產品
    • 細胞和細胞株
    • 套件、培養基和試劑
    • 其他
  • 服務

第5章 工作流程業務分析

  • 工作流程細分儀表板
  • 間質幹細胞市場流程變化分析
  • 2018-2030 年間間質幹細胞市場規模與趨勢分析（依工作流程）
  • 細胞採購與分離
  • 培養及冷凍保存
  • 特性評價

第6章 類型業務分析

  • 類型細分儀表板
  • 間質幹細胞市場類型波動分析
  • 2018-2030年間間質幹細胞市場規模與趨勢分析（按類型）
  • 自體移植
  • 同種異體的

第7章 分拆原因分析

  • 隔離細分儀表板源
  • 間質幹細胞市場分離變異分析來源
  • 2018-2030 年間間質幹細胞市場規模與趨勢分析（依分離來源）
  • 骨髓
  • 臍帶血
  • 週邊血
  • 輸卵管
  • 胎兒肝臟
  • 肺
  • 脂肪組織

第8章 指標業務分析

  • 指示細分儀表板
  • 間質幹細胞市場波動分析
  • 2018-2030年間間質幹細胞市場規模與趨勢分析（依適應症）
  • 骨頭和軟骨修復
  • 循環系統疾病
  • 發炎和免疫疾病
  • 肝病
  • 癌症
  • 移植物抗宿主疾病
  • 其他

第9章 應用業務分析

  • 使用細分儀表板
  • 間質幹細胞市場應用波動分析
  • 2018-2030年間間質幹細胞市場規模與趨勢分析（按應用）
  • 疾病模型
  • 藥物開發和發現
  • 幹細胞銀行
  • 人體組織工程
  • 毒理學研究
  • 其他

第 10 章：按產品和服務、工作流程類型、類型、分離源、徵兆和應用進行區域業務分析

  • 區域儀表板
  • 2023年及2030年市場規模及預測與趨勢分析
  • 北美洲
    • 北美葉幹細胞市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲間質幹細胞市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區間質幹細胞市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲間間質幹細胞市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲間質幹細胞市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章競爭格局

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Cell Applications, Inc.
    • Cyagen Biosciences
    • Axol Bioscience Ltd.
    • STEMCELL Technologies
    • Celprogen Inc.
    • Cellcolabs
    • Stemedica Cell Technologies, Inc.
    • Merck KGaA
    • Lonza
    • PromoCell GmbH
Product Code: GVR-4-68039-361-1

Mesenchymal Stem Cells Market Growth & Trends:

The global mesenchymal stem cells (MSC) market size is expected to reach USD 7.27 billion by 2030, expanding at a CAGR of 12.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S. FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

For instance, on January 2022, the Century Therapeutics and Bristol Myers Squibb entered a collaboration to expand IPSC-derives allogenic cell therapies. In addition, Takeda/TiGenix phase 3 clinical trial incorporated mesenchymal stem cells for complex perianal fistulas in Crohn's Disease. This was the most successful late-stage clinical trial as of September 2020. In addition, in August 2022 AGC Biologics partnered with human mesenchymal stem cell supplier, RoosterBio Inc. to deliver clinically proven advanced therapies for life-threatening conditions. These factors are projected to bolster the usage of stem cell products offered by key entities, thereby intensifying the market competition.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells.

Mesenchymal Stem Cells Market Report Highlights:

  • The products segment dominated the segment and accounted for the largest revenue share of 78.89% in 2023. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment's revenue
  • Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.55% in 2023. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
  • The allogenic MSCs segment accounted for the higher revenue share of 56.60% in 2023. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
  • The bone marrow segment dominated the market and accounted for the largest revenue share of 24.56% in 2023. Bone marrow is a major source of isolation for mesenchymal cells
  • The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.23% in 2023. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
  • North America dominated the market and accounted for the largest revenue share of 45.11% in 2023. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

Table of Contents

Chapter 1. Mesenchymal Stem Cells Market: Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Mesenchymal Stem Cells Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Mesenchymal Stem Cells Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expanding pipeline and clinical studies of mesenchymal stem cell based products
      • 3.2.1.2. Emerging applications of MSCs
      • 3.2.1.3. Rising market competition among key players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of standardized & regulated delivery of stem cell therapy
      • 3.2.2.2. Ethical & safety concerns controversies associated with human msc therapy
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Mesenchymal Stem Cells Market Product & Services Movement Analysis
  • 4.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Cell & Cell Lines
      • 4.4.2.1. Cell & cell lines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Kits, Media, & Reagents
      • 4.4.3.1. Kits, media, & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. Mesenchymal Stem Cells Market Workflow Movement Analysis
  • 5.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Cell Sourcing & Isolation
    • 5.4.1. Cell sourcing & isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Culture & Cryopreservation
    • 5.5.1. Culture & cryopreservation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Differentiation
    • 5.6.1. Differentiation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Characterization
    • 5.7.1. Characterization market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Type Business Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Mesenchymal Stem Cells Market Type Movement Analysis
  • 6.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 6.4. Autologous
    • 6.4.1. Autologous market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Allogeneic
    • 6.5.1. Allogeneic market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Source of Isolation Business Analysis

  • 7.1. Source of Isolation Segment Dashboard
  • 7.2. Mesenchymal Stem Cells Market Source of Isolation Movement Analysis
  • 7.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Source of Isolation, 2018 to 2030 (USD Million)
  • 7.4. Bone Marrow
    • 7.4.1. Bone marrow market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Cord Blood
    • 7.5.1. Cord blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Peripheral Blood
    • 7.6.1. Peripheral blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Fallopian Tube
    • 7.7.1. Fallopian tube market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. Fetal Liver
    • 7.8.1. Fetal liver market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.9. Lung
    • 7.9.1. Lung market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.10. Adipose Tissues
    • 7.10.1. Adipose tissues market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Indication Business Analysis

  • 8.1. Indication Segment Dashboard
  • 8.2. Mesenchymal Stem Cells Market Indication Movement Analysis
  • 8.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 8.4. Bone & Cartilage Repair
    • 8.4.1. Bone & cartilage repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Cardiovascular Disease
    • 8.5.1. Cardiovascular disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Inflammatory & Immunological Diseases
    • 8.6.1. Inflammatory & immunological diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Liver Diseases
    • 8.7.1. Liver diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. Cancer
    • 8.8.1. Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.9. GvHD
    • 8.9.1. GvHD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.10. Others
    • 8.10.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Application Business Analysis

  • 9.1. Application Segment Dashboard
  • 9.2. Mesenchymal Stem Cells Market Application Movement Analysis
  • 9.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 9.4. Disease Modeling
    • 9.4.1. Disease modeling market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5. Drug Development & Discovery
    • 9.5.1. Drug development & discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6. Stem Cell Banking
    • 9.6.1. Stem cell banking market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7. Tissue Engineering
    • 9.7.1. Tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.8. Toxicology Studies
    • 9.8.1. Toxicology studies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.9. Others
    • 9.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Regional Business Analysis by Product & Services, Workflow Type, Type, Source of Isolation, Indication, and Application

  • 10.1. Regional Dashboard
  • 10.2. Market Size & Forecast and Trend Analysis, 2023 & 2030
  • 10.3. North America
    • 10.3.1. North America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.3.2. U.S.
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Target Disease Prevalence
      • 10.3.2.4. U.S. Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Target Disease Prevalence
      • 10.3.3.4. Canada Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Target Disease Prevalence
      • 10.4.2.4. UK Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Target Disease Prevalence
      • 10.4.3.4. Germany Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Target Disease Prevalence
      • 10.4.4.4. France Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Target Disease Prevalence
      • 10.4.5.4. Italy Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Target Disease Prevalence
      • 10.4.6.4. Spain Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Target Disease Prevalence
      • 10.4.7.4. Denmark Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Target Disease Prevalence
      • 10.4.8.4. Sweden Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Target Disease Prevalence
      • 10.4.9.4. Norway Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Target Disease Prevalence
      • 10.5.2.4. Japan Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Target Disease Prevalence
      • 10.5.3.4. China Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Target Disease Prevalence
      • 10.5.4.4. India Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.5. Australia
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Target Disease Prevalence
      • 10.5.5.4. Australia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.6. Thailand
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Target Disease Prevalence
      • 10.5.6.4. Thailand Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.5.7. South Korea
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Target Disease Prevalence
      • 10.5.7.4. South Korea Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Target Disease Prevalence
      • 10.6.2.4. Brazil Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.6.3. Mexico
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Target Disease Prevalence
      • 10.6.3.4. Mexico Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.6.4. Argentina
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Competitive Scenario
      • 10.6.4.3. Target Disease Prevalence
      • 10.6.4.4. Argentina Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.7. MEA
    • 10.7.1. MEA Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Target Disease Prevalence
      • 10.7.2.4. South Africa Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Target Disease Prevalence
      • 10.7.3.4. Saudi Arabia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Target Disease Prevalence
      • 10.7.4.4. UAE Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Target Disease Prevalence
      • 10.7.5.4. Kuwait Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
  • 11.2. Strategy Mapping
  • 11.3. Company Market Position Analysis, 2023
  • 11.4. Company Profiles/Listing
    • 11.4.1. Thermo Fisher Scientific, Inc.
      • 11.4.1.1. Overview
      • 11.4.1.2. Financial Performance
      • 11.4.1.3. Product Benchmarking
      • 11.4.1.4. Strategic Initiatives
    • 11.4.2. Cell Applications, Inc.
      • 11.4.2.1. Overview
      • 11.4.2.2. Product Benchmarking
      • 11.4.2.3. Strategic Initiatives
    • 11.4.3. Cyagen Biosciences
      • 11.4.3.1. Overview
      • 11.4.3.2. Product Benchmarking
      • 11.4.3.3. Strategic Initiatives
    • 11.4.4. Axol Bioscience Ltd.
      • 11.4.4.1. Overview
      • 11.4.4.2. Product Benchmarking
      • 11.4.4.3. Strategic Initiatives
    • 11.4.5. STEMCELL Technologies
      • 11.4.5.1. Overview
      • 11.4.5.2. Product Benchmarking
      • 11.4.5.3. Strategic Initiatives
    • 11.4.6. Celprogen Inc.
      • 11.4.6.1. Overview
      • 11.4.6.2. Product Benchmarking
      • 11.4.6.3. Strategic Initiatives
    • 11.4.7. Cellcolabs
      • 11.4.7.1. Overview
      • 11.4.7.2. Product Benchmarking
      • 11.4.7.3. Strategic Initiatives
    • 11.4.8. Stemedica Cell Technologies, Inc.
      • 11.4.8.1. Overview
      • 11.4.8.2. Product Benchmarking
      • 11.4.8.3. Strategic Initiatives
    • 11.4.9. Merck KGaA
      • 11.4.9.1. Overview
      • 11.4.9.2. Financial Performance
      • 11.4.9.3. Product Benchmarking
      • 11.4.9.4. Strategic Initiatives
    • 11.4.10. Lonza
      • 11.4.10.1. Overview
      • 11.4.10.2. Financial Performance
      • 11.4.10.3. Product Benchmarking
      • 11.4.10.4. Strategic Initiatives
    • 11.4.11. PromoCell GmbH
      • 11.4.11.1. Overview
      • 11.4.11.2. Product Benchmarking
      • 11.4.11.3. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 4 North America mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 5 North America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 6 North America mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 7 North America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 8 North America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 10 U.S. mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 11 U.S. mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 13 U.S. mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 14 U.S. mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 16 Canada mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 17 Canada mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 18 Canada mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 19 Canada mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 20 Canada mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 21 Europe mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
  • Table 22 Europe mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 23 Europe mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 24 Europe mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 25 Europe mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 26 Europe mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Europe mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 29 Germany mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 30 Germany mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 31 Germany mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 32 Germany mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 33 Germany mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 34 UK mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 35 UK mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 36 UK mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 37 UK mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 38 UK mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 39 UK mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 40 France mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 41 France mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 42 France mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 43 France mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 44 France mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 45 France mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 46 Italy mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 47 Italy mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 48 Italy mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 49 Italy mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 50 Italy mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Italy mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 52 Spain mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 53 Spain mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 54 Spain mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 55 Spain mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 56 Spain mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Spain mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 58 Denmark mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 59 Denmark mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 60 Denmark mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 61 Denmark mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 62 Denmark mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 63 Denmark mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 64 Sweden mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 65 Sweden mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 66 Sweden mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 67 Sweden mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 68 Sweden mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 69 Sweden mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 70 Norway mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 71 Norway mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 72 Norway mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 73 Norway mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 74 Norway mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Norway mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 83 China mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 84 China mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 85 China mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 86 China mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 87 China mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 88 China mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 89 Japan mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 90 Japan mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 91 Japan mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 92 Japan mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 93 Japan mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Japan mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 95 India mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 96 India mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 97 India mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 98 India mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 99 India mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 100 India mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 101 South Korea mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 102 South Korea mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 103 South Korea mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Korea mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 105 South Korea mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 106 South Korea mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 107 Australia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 108 Australia mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 109 Australia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 110 Australia mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 111 Australia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 112 Australia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 113 Thailand mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 114 Thailand mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 115 Thailand mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 116 Thailand mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 117 Thailand mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 118 Thailand mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 119 Latin America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 120 Latin America mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 121 Latin America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 122 Latin America mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 123 Latin America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 124 Latin America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 125 Brazil mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 126 Brazil mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 127 Brazil mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 128 Brazil mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 129 Brazil mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 130 Brazil mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 131 Mexico mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 132 Mexico mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 133 Mexico mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 134 Mexico mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 135 Mexico mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 136 Mexico mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 137 Argentina mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 138 Argentina mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 139 Argentina mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 140 Argentina mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 141 Argentina mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 142 Argentina mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 143 MEA mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
  • Table 144 MEA mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 145 MEA mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 146 MEA mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 147 MEA mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 148 MEA mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 149 MEA mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 150 South Africa mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 151 South Africa mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 152 South Africa mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 153 Saudi Arabia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 154 Saudi Arabia mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 155 Saudi Arabia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 156 Saudi Arabia mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 157 Saudi Arabia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 158 Saudi Arabia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 159 UAE mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 160 UAE mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 161 UAE mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 162 UAE mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 163 UAE mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 164 UAE mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
  • Table 165 Kuwait mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
  • Table 166 Kuwait mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
  • Table 167 Kuwait mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
  • Table 168 Kuwait mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
  • Table 169 Kuwait mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
  • Table 170 Kuwait mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Mesenchymal stem cells market: market outlook
  • Fig. 14 Mesenchymal stem cells competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Mesenchymal stem cells market driver impact
  • Fig. 20 Mesenchymal stem cells market restraint impact
  • Fig. 21 Mesenchymal stem cells market strategic initiatives analysis
  • Fig. 22 Mesenchymal stem cells market: Products & services movement analysis
  • Fig. 23 Mesenchymal stem cells market: Products & services outlook and key takeaways
  • Fig. 24 Products market estimates and forecast, 2018 - 2030
  • Fig. 25 Cells & cell lines estimates and forecast, 2018 - 2030.
  • Fig. 26 Kits, media, & reagents market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Services market estimates and forecast, 2018 - 2030
  • Fig. 29 Mesenchymal stem cells Market: Workflow type movement Analysis
  • Fig. 30 Mesenchymal stem cells market: Workflow type outlook and key takeaways
  • Fig. 31 Cell sourcing & isolation market estimates and forecasts, 2018 - 2030
  • Fig. 32 Culture & cryopreservation market estimates and forecasts, 2018 - 2030
  • Fig. 33 Differentiation market estimates and forecasts, 2018 - 2030
  • Fig. 34 Characterization market estimates and forecasts, 2018 - 2030
  • Fig. 35 Mesenchymal stem cells Market: Type movement Analysis
  • Fig. 36 Mesenchymal stem cells market: Type outlook and key takeaways
  • Fig. 37 Autologous market estimates and forecasts, 2018 - 2030
  • Fig. 38 Allogenic market estimates and forecasts, 2018 - 2030
  • Fig. 39 Mesenchymal stem cells Market: Source of isolation movement Analysis
  • Fig. 40 Mesenchymal stem cells market: Source of isolation outlook and key takeaways
  • Fig. 41 Bone marrow market estimates and forecasts, 2018 - 2030
  • Fig. 42 Cord blood market estimates and forecasts, 2018 - 2030
  • Fig. 43 Peripheral blood market estimates and forecasts, 2018 - 2030
  • Fig. 44 Fallopian tube market estimates and forecasts, 2018 - 2030
  • Fig. 45 Fetal liver market estimates and forecasts, 2018 - 2030
  • Fig. 46 Lung market estimates and forecasts, 2018 - 2030
  • Fig. 47 Adipose tissues market estimates and forecasts, 2018 - 2030
  • Fig. 48 Mesenchymal stem cells Market: Indication movement Analysis
  • Fig. 49 Mesenchymal stem cells market: Indication outlook and key takeaways
  • Fig. 50 Bone and cartilage repair market estimates and forecasts, 2018 - 2030
  • Fig. 51 Cardiovascular diseases market estimates and forecasts, 2018 - 2030
  • Fig. 52 Inflammatory and immunological diseases market estimates and forecasts, 2018 - 2030
  • Fig. 53 Liver diseases market estimates and forecasts, 2018 - 2030
  • Fig. 54 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 55 GvHD market estimates and forecasts, 2018 - 2030
  • Fig. 56 Others market estimates and forecasts, 2018 - 2030
  • Fig. 57 Mesenchymal stem cells market: application movement analysis
  • Fig. 58 Mesenchymal stem cells market: application outlook and key takeaways
  • Fig. 59 Disease modeling market estimates and forecasts, 2018 - 2030
  • Fig. 60 Drug development & discovery market estimates and forecasts, 2018 - 2030
  • Fig. 61 Stem cell banking market estimates and forecasts, 2018 - 2030
  • Fig. 62 Tissue engineering market estimates and forecasts, 2018 - 2030
  • Fig. 63 Toxicology studies market estimates and forecasts, 2018 - 2030
  • Fig. 64 Others market estimates and forecasts, 2018 - 2030
  • Fig. 65 Global mesenchymal stem cells market: Regional movement analysis
  • Fig. 66 Global mesenchymal stem cells market: Regional outlook and key takeaways
  • Fig. 67 North America market estimates and forecasts, 2018 - 2030
  • Fig. 68 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 69 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 70 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 71 UK market estimates and forecasts, 2018 - 2030
  • Fig. 72 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 76 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 78 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 79 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 80 China market estimates and forecasts, 2018 - 2030
  • Fig. 81 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 82 India market estimates and forecasts, 2018 - 2030
  • Fig. 83 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 84 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 87 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 89 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 93 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players - Mesenchymal stem cells market